Please login to the form below

Not currently logged in
Email:
Password:

Takeda denies Nycomed takeover talks

Takeda has denied reports that it is to buy Swiss company Nycomed

Japan's Takeda Pharmaceutical Company has denied reports that it is in talks to buy privately-held Nycomed, in a deal worth more than 1tn Japanese yen (£7bn).

In a statement the company said: "Takeda has not agreed to any such agreement as suggested by certain newspaper publications… Takeda is constantly seeking and evaluating opportunities to increase shareholder value and enhance our business through strategic investment, however, there is nothing that needs to be announced at this point."

Initial media reports alleged that the deal was in its final stages, while another said that Takeda is talking to banks about financing the deal.

Earlier this week Takeda announced the start of its 2011-2013 plan to transform the company. It said it will invest strongly on core therapeutic areas and will shift from a product mix centred on mature, large-scale products, to a more diverse product line up centred on new treatments.

The company will also look to accelerate its globalisation activities by making strong investments in newly penetrated countries and emerging markets.

16th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

1000 Voices Survey
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went...
COVID-19 vaccine
How will COVID-19 affect uptake of vaccinations against other diseases?
Will COVID-19 help or hinder the quest to increase uptake of other vaccinations?...
How community outreach can help improve diversity in clinical research
To execute a considered community engagement strategy, an involved and collaborative process is needed....

Infographics